Abstract
Overview
Introduction
Type 2 diabetes is an emerging epidemic driven by the escalating prevalence of
obesity and by an ageing population. Diagnosis rates will continue to increase
as improved awareness raises the public profile of the disease. Despite
several established classes of oral anti-diabetic agents an unmet need for a
safe, efficacious agent which can halt or reverse long-term disease
progression remains.
Scope
- Survey of 180 PCPs, medical diabetologists and endocrinologists conducted
in the seven major markets
- Comparison of physician survey with recent clinical developments, clinical
trial results and current clinical guidelines
- Investigation of clinical unmet needs
Report Highlights
Type 2 diabetes is an emerging epidemic with an estimated 55 million people
affected by the condition in the seven major markets. Despite the raise
profile of the disease physician research reveals that only approximately 50%
of patients are diagnosed and of those around 80% receive treatment
Novel classes of incretin mimetics, GLP-1 agonist and DDP-IV inhibitors, have
the potential to improve time to secondary failure and are likely to be
adopted by international guidelines in the near future. Despite the launch of
these new products significant unmet needs remain in drug efficacy, safety and
disease progression.
Long-term safety data is expected to become increasingly important following
safety issues raised by recent meta-analyses of rosiglitazone over ischemic
events. This will raise the safety bar for new products and is likely to lead
to new classes requiring a long safety record before they are recommended as
1st- or 2nd- line therapies
Reasons to Purchase
- Assess how changes in diagnosis rates will influence the type 2 diabetes
market
- Identify the changes in physician prescription habits and the changes in
complication rates and analyze the impact of changes in treatment decisions
- Benchmark brand awareness and perceptions surrounding product positioning
in order to formulate competitive lifecycle management strategies
| 
View Cart
